MAPK3 and depressive symptom measurement: Specifically, the therapeutic effects of Apelin-13 on depression and memory deficits in rats in the forced swimming test (FST) are blocked by LY294002 (a PI3K inhibitor) or PD98059 (an ERK1/2 inhibitor).